Sucheta Telang

11.9k total citations
52 papers, 2.9k citations indexed

About

Sucheta Telang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sucheta Telang has authored 52 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cancer Research, 31 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Sucheta Telang's work include Cancer, Hypoxia, and Metabolism (31 papers), Cancer-related Molecular Pathways (19 papers) and Metabolism, Diabetes, and Cancer (13 papers). Sucheta Telang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (31 papers), Cancer-related Molecular Pathways (19 papers) and Metabolism, Diabetes, and Cancer (13 papers). Sucheta Telang collaborates with scholars based in United States, Spain and Türkiye. Sucheta Telang's co-authors include Jason Chesney, Brian F. Clem, Amy Clem, Abdullah Yalçın, Andrew N. Lane, John W. Eaton, Sengodagounder Arumugam, John O. Trent, Yoannis Imbert-Fernandez and Kristin K. Nelson and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sucheta Telang

51 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sucheta Telang United States 27 1.8k 1.5k 613 400 241 52 2.9k
Bo Tang China 28 1.8k 1.0× 932 0.6× 593 1.0× 639 1.6× 189 0.8× 70 2.9k
Sybille Mazurek Germany 24 2.3k 1.3× 1.8k 1.3× 537 0.9× 277 0.7× 330 1.4× 45 3.4k
Paula J. Hurley United States 20 1.9k 1.0× 1.5k 1.0× 850 1.4× 863 2.2× 246 1.0× 38 3.3k
David Llobet‐Navàs Spain 27 2.4k 1.3× 1.4k 1.0× 620 1.0× 466 1.2× 182 0.8× 46 3.4k
Jian Xu China 32 1.8k 1.0× 888 0.6× 420 0.7× 472 1.2× 286 1.2× 112 3.0k
Yujuan Dong China 32 2.9k 1.6× 1.9k 1.3× 670 1.1× 209 0.5× 204 0.8× 48 3.7k
Catia Giovannini Italy 25 2.5k 1.4× 2.0k 1.4× 930 1.5× 273 0.7× 288 1.2× 52 3.6k
Ioannis S. Pateras Greece 28 1.5k 0.8× 790 0.5× 993 1.6× 568 1.4× 193 0.8× 77 2.8k
Manfred Kunz Germany 34 2.3k 1.2× 1.2k 0.8× 806 1.3× 970 2.4× 327 1.4× 114 3.8k
Ming Luo China 28 2.3k 1.2× 1.4k 1.0× 1.3k 2.1× 558 1.4× 204 0.8× 82 3.9k

Countries citing papers authored by Sucheta Telang

Since Specialization
Citations

This map shows the geographic impact of Sucheta Telang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sucheta Telang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sucheta Telang more than expected).

Fields of papers citing papers by Sucheta Telang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sucheta Telang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sucheta Telang. The network helps show where Sucheta Telang may publish in the future.

Co-authorship network of co-authors of Sucheta Telang

This figure shows the co-authorship network connecting the top 25 collaborators of Sucheta Telang. A scholar is included among the top collaborators of Sucheta Telang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sucheta Telang. Sucheta Telang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telang, Sucheta, et al.. (2023). Abstract 461: Targeting glucose metabolism in lung cancer. Cancer Research. 83(7_Supplement). 461–461. 1 indexed citations
2.
Truong, Thu H., Nuri A. Temiz, Ying Wang, et al.. (2021). PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer. Oncogene. 40(25). 4384–4397. 26 indexed citations
3.
Telang, Sucheta, et al.. (2019). Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non–small cell lung cancer cell survival. Journal of Biological Chemistry. 294(27). 10530–10543. 29 indexed citations
4.
Mondal, Susmita, Debarshi Roy, Sayantani Sarkar Bhattacharya, et al.. (2018). Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. International Journal of Cancer. 144(1). 178–189. 120 indexed citations
5.
Vanherwegen, An-Sofie, Guy Eelen, Gabriela B. Ferreira, et al.. (2018). Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism. The Journal of Steroid Biochemistry and Molecular Biology. 187. 134–145. 70 indexed citations
6.
Liu, Yongqing, Xiaoqin Lu, Li Huang, et al.. (2014). Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nature Communications. 5(1). 5660–5660. 59 indexed citations
7.
Liu, Yongqing, Ester Sànchez‐Tilló, Xiaoqin Lu, et al.. (2013). Sequential Inductions of the ZEB1 Transcription Factor Caused by Mutation of Rb and Then Ras Proteins Are Required for Tumor Initiation and Progression. Journal of Biological Chemistry. 288(16). 11572–11580. 28 indexed citations
8.
Liu, Yongqing, Ester Sànchez‐Tilló, Xiaoqin Lu, et al.. (2013). The ZEB1 Transcription Factor Acts in a Negative Feedback Loop with miR200 Downstream of Ras and Rb1 to Regulate Bmi1 Expression. Journal of Biological Chemistry. 289(7). 4116–4125. 35 indexed citations
9.
Liu, Yongqing, Ester Sànchez‐Tilló, Xiaoqin Lu, et al.. (2013). Rb1 family mutation is sufficient for sarcoma initiation. Nature Communications. 4(1). 2650–2650. 23 indexed citations
10.
Telang, Sucheta, Kristin K. Nelson, Deanna Siow, et al.. (2012). Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth. Molecular Cancer. 11(1). 60–60. 17 indexed citations
11.
Telang, Sucheta, Brian F. Clem, Alden C. Klarer, et al.. (2012). Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation. Journal of Translational Medicine. 10(1). 95–95. 76 indexed citations
12.
Clem, Brian F., Amy Clem, Abdullah Yalçın, et al.. (2011). A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling. Oncogene. 30(30). 3370–3380. 62 indexed citations
13.
Yalçın, Abdullah, Brian F. Clem, Alan J. Simmons, et al.. (2009). Nuclear Targeting of 6-Phosphofructo-2-kinase (PFKFB3) Increases Proliferation via Cyclin-dependent Kinases. Journal of Biological Chemistry. 284(36). 24223–24232. 188 indexed citations
14.
Yalçın, Abdullah, Sucheta Telang, Brian F. Clem, & Jason Chesney. (2009). Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer. Experimental and Molecular Pathology. 86(3). 174–179. 306 indexed citations
15.
Liu, Yongqing, Brian F. Clem, Ewa Zuba‐Surma, et al.. (2009). Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype. Cell stem cell. 4(4). 336–347. 76 indexed citations
16.
Rasku, Mary Ann, Amy Clem, Sucheta Telang, et al.. (2008). Transient T cell depletion causes regression of melanoma metastases. Journal of Translational Medicine. 6(1). 12–12. 118 indexed citations
17.
Clem, Amy, Jonathan T. Sims, Sucheta Telang, John W. Eaton, & Jason Chesney. (2007). Virus detection and identification using random multiplex (RT)-PCR with 3'-locked random primers. Virology Journal. 4(1). 65–65. 28 indexed citations
18.
Telang, Sucheta, Andrew N. Lane, Kristin K. Nelson, Sengodagounder Arumugam, & Jason Chesney. (2007). The oncoprotein H-RasV12 increases mitochondrial metabolism. Molecular Cancer. 6(1). 77–77. 60 indexed citations
19.
Telang, Sucheta, Amy Clem, John W. Eaton, & Jason Chesney. (2007). Depletion of Ascorbic Acid Restricts Angiogenesis and Retards Tumor Growth in a Mouse Model. Neoplasia. 9(1). 47–56. 52 indexed citations
20.
Chesney, Jason, et al.. (2005). Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality. Biochemical and Biophysical Research Communications. 331(1). 139–146. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bo Tang Breakdown of academic impact, for papers by Sybille Mazurek Breakdown of academic impact, for papers by Paula J. Hurley Breakdown of academic impact, for papers by David Llobet‐Navàs Breakdown of academic impact, for papers by Jian Xu Breakdown of academic impact, for papers by Yujuan Dong Breakdown of academic impact, for papers by Catia Giovannini Breakdown of academic impact, for papers by Ioannis S. Pateras Breakdown of academic impact, for papers by Manfred Kunz Breakdown of academic impact, for papers by Ming Luo
Rankless by CCL
2026